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Abstract
We encountered cardiac arrest induced by 0.375 % ropivacaine 7 ml administered via a catheter for continuous
thoracic paravertebral block (TPVB) in a 6-year-old female who underwent pacemaker implantation for sick sinus
syndrome (SSS). She was successfully resuscitated with adrenaline and lipid emulsion. Plasma concentration of
ropivacaine was 5.2 μg/ml, suggesting intravascular administration of ropivacaine. Inadvertent intravascular
administration is a crucial complication of TPVB.
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Background
TPVB is effective for intra- and postoperative analgesia
for thoracotomy and laparotomy in children as well as in
adults [1, 2]. Although it has been considered to be safer
than epidural anesthesia from the point of epidural
hematoma and spinal cord injury, as well as being able
to be performed with ultrasound guidance, rare com-
plications such as vascular puncture may occur [3]. We
report a case of cardiac arrest in a child induced by
ropivacaine administered via an indwelling catheter for
TPVB.
Case presentation
A 6-year-old, 14 kg, 91 cm girl with trisomy 21 was
scheduled for elective pacemaker implantation with lead
attachment to the epicardium under thoracotomy. She
was born with trisomy 21, and presented with coarcta-
tion of aorta and atrioventricular septal defect, which
have being surgically repaired at the age of 9 days and
9 months, respectively. SSS as well as bradycardia-
tachycardia syndrome was diagnosed by manifestation of
bradycardia and tachycardia after the surgical repair of
mitral insufficiency at the age of 3 years. Her pulse con-
trol was unfavorable despite the administration of iso-
prenaline hydrochloride, leading to a decision of
pacemaker implantation. Diazepam (9 mg) was given as
a premedication. Anesthesia was induced uneventfully
with sevoflurane (5 %) in 66 % nitrous oxide and 33 %
oxygen although we prepared atropine and transcutane-
ous pacing in case of hemodynamic deterioration. After
tracheal intubation, anesthesia was maintained with pro-
pofol (10 to 12 mg/kg/h) and remifentanil (0.1 to 0.2 μg/
kg/min). With anesthesia induction, the heart rate de-
creased from approximately 140/min (atrial tachycardia)
to 120/min, changing from atrial tachycardia to atrial flut-
ter, but the blood pressure was maintained. The
ultrasound-guided TPVB was performed through the 5th
intercostal space, with the patient placed in the right lat-
eral position. A probe was placed in parallel to the costal
bone, and an 18G Tuohy needle was inserted from the lat-
eral side using the in-plane approach. When the needle tip
reached the paravertebral space, 5 mL of saline was in-
fused to confirm the ventral transposition of the pleura
and widening of the paravertebral space. Subsequently, a
catheter was inserted into the paravertebral space (length
of insertion: 3 cm). At this point, a mixture of 3 mL of sa-
line and 0.5 mL of air was injected through the catheter,
but no hyperechoic flash could be confirmed in the para-
vertebral space. Immediately before the start of surgery,
7 mL of 0.375 % ropivacaine (1.85 mg/kg) was adminis-
tered in divided doses over 1 min. At this point, the cath-
eter was aspirated, but there was no blood regurgitation.
Approximately two minutes after the start of ropivacaine
administration, the electrocardiographic waveform
showed asystole. Immediately, chest compression was
started, and adrenaline (0.1 mg) was intravenously admin-
istered, and a pulse was established after approximately
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2 min. Under a tentative diagnosis of intoxication with the
local anesthetic, blood was collected through an arterial
line to measure its plasma concentration (6 min after ropi-
vacaine administration), and 20 mL of 20 % lipid emulsion
was administered (7 min after ropivacaine administration).
As the effect of single-dose administration of adrenaline
gradually decreased over time reducing the blood pressure
(38/20 mmHg) and heart rate (54 beats per minute), the
continuous administration of catecholamine was considered
necessary. After a catheter for transesophageal pacing was
inserted into the esophagus, central venous catheterization
was performed. The continuous administration of adren-
aline (0.03 μg/kg/min), dobutamine (5 μg/kg/min), and
dopamine (5 μg/kg/min) was started. After the he-
modynamic parameters became stable, we decided to
proceed to the surgery because we believed that pace-
maker implantation would also treat the bradycardia
caused by ropivacaine. The surgery was done uneventfully.
When the catheter was examined after surgery, blood into
the catheter (about 12 cm) was observed. Since the blood
had coagulated, the catheter was removed.
The patient was transferred to the intensive care unit
(ICU) while being intubated. Dexmedetomidine (0.4 μg/
kg/h) and fentanyl (0.5 μg/kg/h) were administered to
obtain sedation and analgesia, and tapered gradually.
The patient was extubated 2 days and discharged 13 days
after the surgery without any neurological abnormalities.
Subsequently, the results of examination showed that
the plasma concentration of ropivacaine was 5.2 μg/mL.
Discussion
This is the first report on cardiac arrest resulting
from TPVB-related intoxication with a local anesthetic.
Ropivacaine administered through a catheter may have
flowed into circulation, inducing intoxication resulting in
cardiac arrest for the following reasons: 1) cardiac arrest
occurred immediately after ropivacaine administration,
2) blood regurgitation into the catheter was found after
the completion of surgery, and 3) the results of later
examination showed that the plasma concentration of
ropivacaine was high. At the same time, in the present
case, the influence of sympathetic blockade must be
considered as a cause of cardiac arrest. A catheter for
TPVB was inserted through the 5th intercostal space,
which is adjacent to the cardiac sympathetic branch.
Considering the fact that the patient had SSS, it is not
surprising that sympathetic blockade by ropivacaine ad-
ministered through a catheter may lead to cardiac arrest.
However, there have been no case reports of cardiac arrest
or bradycardia after drug administration for TPVB.
Lönnqvist et al. [3] reported complications related to
paravertebral block in adults and children: 3.8 % of adults
and 4.2 % of children had vascular puncture, and 5 % of
adults and none in children had hypotension. Neither
bradycardia nor cardiac arrest was reported. Regarding
epidural anesthesia, there is a case report in which SSS,
which had not been indicated, became manifest after the
administration of a local anesthetic [4]. However, this did
not lead to cardiac arrest. Based on these findings, sympa-
thetic blockade-related bradycardia does not seem to con-
tribute to cardiac arrest after TPVB, as demonstrated in
the present case.
Although few prospective studies have investigated the
pharmacokinetics or systemic toxicity of ropivacaine,
ropivacaine toxicity in adults and bupivacaine toxicity in
children have been reported. Knudsen et al. [5] reported
that the arterial plasma concentration of ropivacaine at
the onset of symptoms of ropivacaine-related intoxica-
tion was 3.4 to 5.3 μg/mL in adult volunteers. Chazalon
et al. [6] reported an adult with sciatic/saphenous nerve
block-induced bradycardia, leading to cardiac arrest.
They indicated that the plasma concentration of rop-
ivacaine after 70 min was 1.88 μg/mL. Huet et al. [7]
reported that the plasma concentration of ropivacaine
55 min after cardiac arrest associated with lumbar ple-
xus block was 5.61 μg/mL. In addition, Gnaho et al. [8]
indicated that the plasma concentration of ropivacaine
15 min after ventricular fibrillation associated with scia-
tic nerve block was 2.48 μg/mL. Thus, the plasma con-
centration of ropivacaine reportedly ranged from 1.88 to
5.61 μg/mL although the interval from cardiac arrest
until blood collection varied. Agarwal [9] and McCloskey
[10] reported several cases of bupivacaine systemic tox-
icity secondary to continuous infusion (caudal epidural
and intrapleural) in children. The blood levels at the
time of seizures (four cases, 3 to 9-years-old) ranged
from 5.4 to 10.2 μg/mL. The blood levels in one 3.89 kg-
neonate with the initial episode of ventricular tachycar-
dia was 5.6 μg/mL. Although they have reported bupiva-
caine toxicity, higher plasma concentrations of
ropivacaine may be necessary to induce systemic toxicity
because plasma concentration of ropivacaine was higher
than that of bupivacaine when the symptoms were elic-
ited [5]. In our case, the plasma concentration of ropiva-
caine was 5.2 μg/mL. As the blood was collected 6 min
after cardiac arrest, the concentration at the time of car-
diac arrest may have been higher. Therefore, our patient
may also have had a high enough blood ropivacaine con-
centration to cause cardiac arrest.
To treat cardiac arrest due to intoxication with a local
anesthetic, adrenaline and lipid emulsion are used. In
our case, a single-dose administration of adrenaline im-
mediately after cardiac arrest successfully resumed the
pulse. After a bolus administration of lipid emulsion, be-
cause the heart rate was maintained by adrenaline, the
administration of lipid emulsion was not continued.
However, both the heart rate and blood pressure were
decreasing, requiring transesophageal pacing and the
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continuous administration of adrenaline, the continuous
administration of lipid emulsion may also have been
necessary.
Lastly, we discuss preventive measures of intravascular
administration in TPVB. There are several TPVB-specific
and general measures to prevent intravascular administra-
tion. The first TPVB-specific measure is to confirm a
hyperechoic flash in the paravertebral space. Yoshida et al.
[11] confirmed that the catheter tip was located in the
paravertebral space by injecting a mixture of 3 mL of
saline and 0.5 mL of air through a catheter and confirming
a hyperechoic flash in the paravertebral space. We did not
observe hyperechoic flash, but continued the procedure
because we believed the lack of hyperechoic flash was
possibly due to technical problems, such as inappropriate
direction of the probe-tip. We should have checked the
flash thoroughly. However, when air was administered
several times until a hyperechoic flash is observed, medi-
astinal emphysema or air emboli may develop in children.
The second TPVB-specific method is to confirm the ven-
tral transposition of the pleura using ultrasonography
while drug administration through a catheter [2]. In our
patient, saline was infused not through a catheter, but
through a Tuohy needle, to confirm the ventral transpos-
ition of the pleura. The catheter was inserted 3 cm from
the needle tip, but we could have inserted less considering
the size of her body. Thus, we cannot rule out the possi-
bility of intravascular migration of the catheter tip. We
could have confirmed using ultrasonography if the drug
reached the paravertebral space by administering the
drug through the catheter. However, this method has a
limitation: confirmation is not possible immediately
prior to the operation when ultrasonography is not
available. To avoid intravascular administration, there
are also general measures to be taken. Firstly, there is a
method to confirm blood regurgitation through cath-
eter aspiration, but when an excessive negative pressure
is applied, no blood regurgitation may occur, resulting a
false-negative reaction [8]. We also confirmed blood re-
gurgitation by aspirating the catheter, but found no
blood regurgitation. Therefore, we cannot rule out the
possibility that the negative pressure was excessive. Sec-
ondly, a local anesthetic containing adrenaline is used
as a test dose. When adrenaline enters blood circula-
tion, tachycardia, an increase in blood pressure and
ECG changes, such as T-wave amplitude and ST seg-
ment changes, are observed [12]. However, children
under general anesthesia may be less sensitive to adren-
aline, leading to false-negative reactions in some cases.
Furthermore, when a patient is tachycardic like our pa-
tient, adrenaline must be carefully administered, con-
sidering the influence of the deteriorated tachycardia
on the hemodynamics. Thirdly, it is also important to
administer drug slowly. When administered in divided
doses, the onset of systemic reactions may be delayed
by 60 to 90 s [12]. For administration in divided doses,
it is also necessary to administer the subsequent dose
after a sufficient period of observation.
Conclusions
We encountered cardiac arrest which occurred after
ropivacaine administration for TPVB in a 6-year-old
female. This was possibly due to the intravascular ad-
ministration of ropivacaine. For TPVB, it is important to
combine several measures to prevent intravascular ad-
ministration and administer drugs carefully.
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